VIVA BIOTECH (01873) spent 404,500 Hong Kong dollars to repurchase 450,000 shares on November 15th.

19:15 15/11/2024

Viva Biotech (01873) announced that the company spent 404,500 Hong Kong dollars on November 15, 2024...

VIVA BIOTECH (01873) announces that the company has repurchased 450,000 shares on November 15, 2024, at a total cost of 404,500 Hong Kong dollars, with a repurchase price per share ranging from 0.89 to 0.9 Hong Kong dollars.

Beijing Foyou Pharma (601089.SH): Hydrobromide Xylitol Oral Solution Obtained Drug Registration Certificate

UBS: Upgrades China Minsheng Banking Corp., Ltd. (01988) to "buy", optimistic about profit turning point and valuation reassessment.

NaiXue (02150) New Fiber Studio store lands in Shenzhen Coast! Low GI and high fiber leading the trend of healthy tea drinks.

Beijing Foyou Pharma (601089.SH): Hydrobromide Xylitol Oral Solution Obtained Drug Registration Certificate

UBS: Upgrades China Minsheng Banking Corp., Ltd. (01988) to "buy", optimistic about profit turning point and valuation reassessment.

NaiXue (02150) New Fiber Studio store lands in Shenzhen Coast! Low GI and high fiber leading the trend of healthy tea drinks.